1. Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial. Issue 3 (11th March 2015) Authors: Shaw, E; Miró, J M; Puig-Asensio, M; Pigrau, C; Barcenilla, F; Murillas, J; Garcia-Pardo, G; Espejo, E; Padilla, B; Garcia-Reyne, A; Pasquau, J; Rodriguez-Baño, J; López-Contreras, J; Montero, M; de la Calle, C; Pintado, V; Calbo, E; Gasch, O; Montejo, M; Salavert, M Other Names: Gudiol Francisco collab.; Dominguez M Angeles collab.; Ferrer Anna collab.; Soriano Alex collab.; Almela Manuel collab.; Molas Gloria collab.; Larrosa Maria Nieves collab.; Suñe Pilar collab.; Mirelis Beatriz collab.; Rodriguez-Arias Ainhoa collab.; Gomez Julià collab.; Espona Mercé collab.; Tapi... Journal: BMJ open Issue: Volume 5:Issue 3(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 4CPS-007 Interdisciplinary team in the follow-up of a patient with teduglutida. (2nd March 2018) Authors: Bellver, M; Montero, M; Segui, I; Gil, R; Masia, V; Soler, E Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57). (25th November 2021) Authors: Podzamczer, D; Micán, R; Tiraboschi, J; Portilla, J; Domingo, P; Llibre, J M; Ribera, E; Vivancos, M J; Morano, L; Masiá, M; Gómez, C; Fanjul, F; Payeras, A; Inciarte, A; Estrada, V; Rivero, A; Castro, Á; Bernal, E; Vinuesa, D; Knobel, H Journal: Open forum infectious diseases Issue: Volume 9:Number 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir. Issue 5 (10th September 2015) Authors: Rojas, J; Lonca, M; Imaz, A; Estrada, V; Asensi, V; Miralles, C; Domingo, P; Montero, M; del Rio, L; Fontdevila, J; Perez, I; Cruceta, A; Gatell, JM; Arnedo, M; Martínez, E Journal: HIV medicine Issue: Volume 17:Issue 5(2016:May) Page Start: 340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Very low level viraemia and risk of virological failure in treated HIV‐1‐infected patients. Issue 3 (1st August 2016) Authors: Teira, R; Vidal, F; Muñoz‐Sánchez, P; Geijo, P; Viciana, P; Ribera, E; Domingo, P; Castaño, M; Martínez, E; Roca, B; Puig, T; Estrada, V; Deig, E; Galindo, MJ; de la Fuente, B; Lozano, F; Montero, M; Muñoz‐Sanz, A; Sanchez, T; Terrón, A Journal: HIV medicine Issue: Volume 18:Issue 3(2017:Mar.) Page Start: 196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PKP-010 Higher than recommended doses of colistimethate sodium in patients with multi-drug resistant gram-negative bacterial infections: a benefit or an increased risk of toxicity?. (24th March 2015) Authors: Luque, S; Sorlí, L; Horcajada, J; Campillo, N; Alvarez-Lerma, F; Segura, C; Knobel, H; Montero, M; Garcia, R; Grau, S Journal: European journal of hospital pharmacy Issue: Volume 22(2015)Supplement 1 Page Start: A135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗